The Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world's first international charity dedicated specifically to the eradication of death and suffering from renal cancers.
The Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest organization of its kind, with members in more than 100 countries.
KCA funds, promotes, and collaborates with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA), and other institutions on research projects. It educates families and physicians, and serve as an advocate on behalf of patients at the state and federal levels in the United States and globally.
Resources for Nurses
KCA provides a wide range of resources of help to oncology nurses and other essential members of the patient care team, including clinically oriented videos from various KCA symposia and special events in recent years. These can be accessed at:
http://www.kidneycancer.org/knowledge/learn/videos/
An outstanding resource for oncology nurses is the Kidney Cancer Association Nurse Advisory Board YouTube® video series: “About Targeted Therapies,” which can be accessed at:
www.kidneycancer.org/knowledge/learn/nurse-hotline/#sthash.Y8AMkRdH.dpuf
Nursing-Hotline for Patients
KCA recognizes the unique and important role that oncology nurses play in providing care for cancer patients and assistance to their families and caregivers. Among KCA resources for patients is the Nurse Hotline, which may be reached by telephone Monday through Friday, 8 a.m. to 5 p.m. (Eastern) or by email. The hotline can be accessed at 1-503-215-7921 or by sending an email to:
kidneycancernurse@providence.org
The hotline nurses answer questions about the treatment of kidney cancer, including the management of side effects from therapies for advanced disease. If the nursing is helping someone else when you call, please leave a message, including the best time to return your call. Outside the continental US, email is preferred. They also provide referrals to expert physicians.
As a part of its partnership with Oncology Nursing News, KCA will provide targeted information for kidney cancer patients at this site, starting this fall. To learn more, please visit http://www.kidneycancer.org/.
NCCN Updates Guidelines for Preferred Frontline Regimen for Advanced Nasopharyngeal Carcinoma
December 5th 2024The NCCN Guidelines Version 1.2025 for Cancer of the Nasopharynx listed toripalimab plus chemotherapy as the standalone preferred regimen in the frontline treatment of patients with advanced nasopharyngeal carcinoma.